Biocon's Q2 Results Decoded. Exclusive Interview With Biocon's Management On Earnings & Plans Ahead

In this exclusive interview, Business Today TV's Sakshi Batra speaks with Siddharth Mittal, CEO & MD of Biocon Limited, about the company's Q2 FY25 earnings. Biocon reported total consolidated revenue of Rs 3,623 crore, which was flat year-on-year. The company faced a net loss of Rs 16 crore, a stark contrast to the profit of Rs 126 crore reported last year. Revenue from operations increased by 4% year-on-year to Rs 3,590 crore, while core EBITDA stood at Rs 992 crore, reflecting core operating margins of 28%. The company made net R&D investments of Rs 200 crore, representing 7% of revenue excluding Syngene. EBITDA for the quarter was Rs 718 crore, with a margin of 20%. Siddharth Mittal shares insights into the reasons behind the weak performance and discusses the company's growth plans moving forward. Tune in to hear directly from management about the challenges faced this quarter and their outlook for the future!